Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa
- 1 November 1983
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 16 (4), 401-408
- https://doi.org/10.1099/00222615-16-4-401
Abstract
The bactericidal action of serum from 61 adult patients with cystic fibrosis (CF) against autologous and heterologous strains of P. aeruginosa was studied. CF serum had a similar bactericidal action to normal human serum (NHS) against a reference panel of strains. Six CF sera had a selective inability to kill autologous Pseudomonas strains which were sensitive to NHS and to sera from other CF patients. The 6 sera had normal levels of complement and Ig and were bactericidal to other strains. A titratable blocking factor was present in these sera; it interfered with the bactericidal action of NHS on the appropriate strain. This factor was present in the IgG-containing fractions of serum obtained by ion-exchange chromatography, but was not removed from the serum by absorption with the Pseudomonas strain. Some CF sera may fail to kill sensitive strains of Pseudomonas because of the development of a blocking IgG antibody against naturally-occurring bactericidal IgM antibody.This publication has 3 references indexed in Scilit:
- Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patientsInfection and Immunity, 1981
- PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS - BACTERICIDAL EFFECT OF SERUM FROM NORMAL INDIVIDUALS AND PATIENTS WITH CYSTIC-FIBROSIS ON P AERUGINOSA STRAINS FROM PATIENTS WITH CYSTIC-FIBROSIS OR OTHER DISEASES1977
- CYSTIC-FIBROSISPublished by Elsevier ,1976